Skip to content

Effectiveness of Transcranial Direct Current Stimulation (tDCS).

Effectiveness of Transcranial Direct Current Stimulation (tDCS) in Musculoskeletal Rehabilitation.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04902274
Enrollment
41
Registered
2021-05-26
Start date
2020-08-19
Completion date
2021-12-17
Last updated
2022-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Sprains, Musculoskeletal Injury

Brief summary

Reducing pain and recovery of strength and function are major challenges in physical therapy. Transcranial direct current stimulation (tDCS) is a novel intervention that has gained popularity in the rehabilitation of athletic injuries, pain management, and sports performance. Acute application of tDCS has been shown to modulate the perception of effort and fatigue, enhance motor learning, improve endurance performance, and improve muscular power and strength. tDCS has also been shown to reduce pain in patients with chronic pain conditions. Using a double-blind, randomized clinical trial design, we aim to evaluate the effectiveness of tDCS plus standard rehabilitation compared to rehabilitation alone on pain, balance and proprioception, functional performance, and strength following acute ankle inversion sprain. We hypothesize that the group using tDCS will demonstrate superior outcomes in all variables of interest.

Interventions

OTHERTranscranial Direct Current Stimulation

The Halo Sport (Halo Neuroscience, San Francisco, CA) is a commercial off-the-shelf tDCS device that delivers a 2.2 mA current to the motor cortex through three elastomer foam scalp pads with a 24 sq. cm surface area (see https://www.haloneuro.com/). The tDCS is controlled through the Halo Sport App where the therapist and patient are blind to an actual or sham treatment. Patients in the tDCS group will complete a 20-minute tDCS session while performing the warm-up.

OTHERSham Transcranial Direct Current Stimulation

The Halo Sport (Halo Neuroscience, San Francisco, CA) is a commercial off-the-shelf tDCS device that delivers a 2.2 mA current to the motor cortex through three elastomer foam scalp pads with a 24 sq. cm surface area (see https://www.haloneuro.com/). The tDCS is controlled through the Halo Sport App where the therapist and patient are blind to an actual or sham treatment. Patients in the sham tDCS group will complete a 20-minute sham-tDCS session while performing the warm-up, but the app will discontinue the treatment after 30 seconds.

OTHERPhysical Therapy

After the tDCS session is complete, the patient will complete treatment consistent with the standard of care for rehabilitation of acute ankle inversion sprain. The rehabilitation program will be standardized among all patients and will consist of therapeutic exercises, manual physical therapy, and other modalities. Rehabilitation sessions will be performed 2x weekly and sessions will last approximately 45 to 60 minutes. Patients will also perform a standardized home exercise program that reinforces the in-clinic treatment.

Sponsors

Keller Army Community Hospital
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18-40 2. Within 2-weeks s/p acute grade 1 or 2 ankle inversion sprain

Exclusion criteria

1. Self-Reported Pregnancy 2. Being treated for and on medication for a mental health diagnosis 3. Concussion or non-lateral ankle sprain lower extremity injuries within the past 6 months 4. Open wound or dermatologic lesion on the head or region of application 5. Active implantable medical devices such as cochlear implants or cardiac pacemakers, or with metal implants in the head (excluding standard orthodontic braces, fillings, etc.). 6. Epilepsy or history of seizures 7. Participants who are not fluent in English

Design outcomes

Primary

MeasureTime frameDescription
Composite Pain RatingChange from Baseline to 4-weeksNumerical Pain Rating Scale assessment of Current, Best 24-hour, Worst 24-hour Pain

Secondary

MeasureTime frameDescription
Self-Reported FunctionChange from Baseline to 4-weeksPatient report of function assessed by Single Assessment Numeric Evaluation
Muscle StrengthChange from Baseline to 4-weeksIsometric dorsiflexion, plantarflexion, inversion, eversion assessed by hand-held dynamometry
ProprioceptionChange from Baseline to 4-weeksLimits of stability test and unilateral stance test assessed by NeuroCom EquiTest
Dynamic balanceChange from Baseline to 4-weeksDynamic balance assessed by the Y-balance Test
Muscle PowerChange from Baseline to 4-weeksSingle leg hop test for distance

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026